Press Releases on December 20, 2018 - EIN Presswire - Press Release Distribution Service

Published on December 20, 2018 - 21:05 GMT

First Financial Northwest, Inc. Announces Appointment of Randy Riffle As Executive Vice President And Chief Credit Officer of ...

RENTON, Wash., Dec. 20, 2018 (GLOBE NEWSWIRE) -- First Financial Northwest, Inc. (the “Company”) (NASDAQ GS: FFNW), the holding company for First Financial Northwest Bank (the “Bank”) today announced that Randy Riffle has been appointed Executive Vice …

Distribution channels: Banking, Finance & Investment Industry ...

Published on December 20, 2018 - 21:05 GMT

Alta Mesa Announces Leadership Transition

HOUSTON, Dec. 20, 2018 (GLOBE NEWSWIRE) -- Alta Mesa Resources, Inc. (NASDAQ: AMR, “Alta Mesa Resources” or the “Company”) today announced the resignations of Harlan H. Chappelle, President and Chief Executive Officer, and Michael E. Ellis, Vice President …

Distribution channels: Banking, Finance & Investment Industry, Energy Industry ...

Published on December 20, 2018 - 21:05 GMT

CPI Aerostructures Completes Acquisition of Welding Metallurgy, Inc.

EDGEWOOD, N.Y., Dec. 20, 2018 (GLOBE NEWSWIRE) -- CPI Aerostructures, Inc. (“CPI Aero”) (NYSE American: CVU) today announced that it has completed its acquisition of Welding Metallurgy, Inc. (“WMI”) from Air Industries Group, Inc. in a transaction valued …

Distribution channels: Banking, Finance & Investment Industry, Technology ...

Published on December 20, 2018 - 21:05 GMT

Halcón Resources Announces the Closing of its Water Infrastructure Asset Divestiture

Denver, Colorado, Dec. 20, 2018 (GLOBE NEWSWIRE) -- Halcón Resources Corporation (NYSE:HK) (“Halcón” or the “Company”) today announced it has closed on the previously announced divestiture of all of its water infrastructure assets across the Delaware Basin …

Distribution channels: Banking, Finance & Investment Industry, Energy Industry ...

Published on December 20, 2018 - 21:04 GMT

MERGER ALERT – BLMT and GPIC: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies

NEW YORK, Dec. 20, 2018 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP: Levi & Korsinsky, LLP announces that investigations have commenced on behalf of shareholders of the following publicly-traded companies. …

Distribution channels: Consumer Goods, Law ...

Published on December 20, 2018 - 21:01 GMT

RBBN CLASS ACTION DEADLINE: Rosen Law Firm Reminds Ribbon Communications, Inc. Investors of Important Deadline in Class Action ...

NEW YORK, Dec. 20, 2018 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Ribbon Communications, Inc. f/k/a Sonus Networks, Inc. (NASDAQ: RBBN) from January 8, 2015 through March 24, 2015, …

Distribution channels: Consumer Goods, Law ...

Published on December 20, 2018 - 21:01 GMT

Landmark Infrastructure Partners LP Announces Cash Distribution for its 8.00% Series A Preferred Units

EL SEGUNDO, Calif., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Landmark Infrastructure Partners LP (the “Partnership”) (NASDAQ: LMRK) announced today that the board of directors of its general partner declared a quarterly cash distribution for its 8.00% Series A …

Distribution channels: Banking, Finance & Investment Industry, Real Estate & Property Management ...

Published on December 20, 2018 - 21:01 GMT

Apellis Pharmaceuticals’ APL-2 Receives Orphan Drug Designation from the FDA for the Treatment of C3 Glomerulopathy

CRESTWOOD, Ky. and WALTHAM, Mass., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc., (Nasdaq:APLS) a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat diseases through inhibition of …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on December 20, 2018 - 21:01 GMT

ARCA biopharma Updates Special Protocol Assessment Request to FDA for Gencaro Phase 3 Atrial Fibrillation Clinical Trial

Phase 3 atrial fibrillation trial planned in population with no effective or FDA approved therapies PRECISION-AF, planned Phase 3 clinical trial in patients with genotype that responds most favorably to Gencaro WESTMINSTER, Colo., Dec. 20, 2018 (GLOBE …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on December 20, 2018 - 21:01 GMT

RF Industries Reports Q4 Income From Continuing Operations of $0.9 million, $0.09 EPS; Record Net Income of $5.8 Million, $0.61 ...

SAN DIEGO, Dec. 20, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- RF Industries, Ltd, (NASDAQ: RFIL), a national manufacturer and marketer of interconnect products and systems, today announced its financial results for the fourth quarter and fiscal year …

Distribution channels: Banking, Finance & Investment Industry